Millennium Management’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-660,664
| Closed | -$6.67M | – | 5744 |
|
|
2022
Q4 | $6.67M | Buy |
660,664
+8,000
| +1% | +$80.7K | ﹤0.01% | 1908 |
|
|
2022
Q3 | $6.47M | Buy |
652,664
+188,697
| +41% | +$1.87M | ﹤0.01% | 1991 |
|
|
2022
Q2 | $4.55M | Buy |
463,967
+22,090
| +5% | +$217K | ﹤0.01% | 2242 |
|
|
2022
Q1 | $4.34M | Sell |
441,877
-3,270
| -0.7% | -$32.1K | ﹤0.01% | 2418 |
|
|
2021
Q4 | $4.33M | Buy |
445,147
+109,157
| +32% | +$1.06M | ﹤0.01% | 2363 |
|
|
2021
Q3 | $3.26M | Buy |
335,990
+104,000
| +45% | +$1.01M | ﹤0.01% | 2592 |
|
|
2021
Q2 | $2.24M | Buy |
+231,990
| New | +$2.24M | ﹤0.01% | 3041 |
|